Related references
Note: Only part of the references are listed.Cancer prevention as part of precision medicine: 'plenty to be done'
Bernard W. Stewart et al.
CARCINOGENESIS (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Transforming Cancer Prevention through Precision Medicine and Immune-oncology
Thomas W. Kensler et al.
CANCER PREVENTION RESEARCH (2016)
Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
Roman M. Chabanon et al.
CLINICAL CANCER RESEARCH (2016)
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
Judith Balmana et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Hannah Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array
Rajesh R. Singh et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care
Jeremy L. Warner et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling
Matthew J. Rioth et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)
SMART on FHIR: a standards-based, interoperable apps platform for electronic health records
Joshua C. Mandel et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
Uncertainty in the Era of Precision Medicine
David J. Hunter
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genetic Misdiagnoses and the Potential for Health Disparities
Arjun K. Manrai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome
Alexandria D. Taylor et al.
TRANSLATIONAL ONCOLOGY (2016)
Sequencing Structural Variants in Cancer for Precision Therapeutics
Geoff Macintyre et al.
TRENDS IN GENETICS (2016)
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B. Johnson et al.
NATURE COMMUNICATIONS (2016)
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
Andrea Garofalo et al.
GENOME MEDICINE (2016)
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Kasmintan A. Schrader et al.
JAMA ONCOLOGY (2016)
Data Sharing to Support the Cancer Journey in the Digital Era
John C. Krauss et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Implementing and Improving Automated Electronic Tumor Molecular Profiling
Matthew J. Rioth et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
A Survey of U.S Adults' Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment
David J. Kaufman et al.
PLOS ONE (2016)
The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies
Sara E. Patterson et al.
HUMAN GENOMICS (2016)
ALK immunohistochemistry for ALK gene rearrangement screening in non-small cell lung cancer: a systematic review and meta-analysis
Jung-Soo Pyo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2016)
Clinical Documentation in the 21st Century: Executive Summary of a Policy Position Paper From the American College of Physicians
Thomson Kuhn et al.
ANNALS OF INTERNAL MEDICINE (2015)
Single-Cell Mass Cytometry Reveals Intracellular Survival/Proliferative Signaling in FLT3-ITD-Mutated AML Stem/Progenitor Cells
Lina Han et al.
CYTOMETRY PART A (2015)
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B. Johnson et al.
EUROPEAN JOURNAL OF CANCER (2015)
GenomeConnect: Matchmaking Between Patients, Clinical Laboratories, and Researchers to Improve Genomic Knowledge
Brianne E. Kirkpatrick et al.
HUMAN MUTATION (2015)
Good laboratory practice for clinical next-generation sequencing informatics pipelines
Amy S. Gargis et al.
NATURE BIOTECHNOLOGY (2015)
Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
L. V. Sequist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ClinGen - The Clinical Genome Resource
Heidi L. Rehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetics of melanocytic nevi
Mi Ryung Roh et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Personalized genomic analyses for cancer mutation discovery and interpretation
Sian Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Exome Sequencing: Current and Future Perspectives
Amanda Warr et al.
G3-GENES GENOMES GENETICS (2015)
Driving Innovation in Health Systems through an Apps-Based Information Economy
Kenneth D. Mandl et al.
CELL SYSTEMS (2015)
Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection
Phillip N. Gray et al.
CANCERS (2015)
Genenames.org: the HGNC resources in 2015
Kristian A. Gray et al.
NUCLEIC ACIDS RESEARCH (2015)
Next Generation Ligand Binding Assays-Review of Emerging Technologies' Capabilities to Enhance Throughput and Multiplexing
Johanna Mora et al.
AAPS JOURNAL (2014)
Genome alignment with graph data structures: a comparison
Birte Kehr et al.
BMC BIOINFORMATICS (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Cancer of Unknown Primary Site
Gauri R. Varadhachary et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Hubing Shi et al.
CANCER DISCOVERY (2014)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record
Peter Tarczy-Hornoch et al.
GENETICS IN MEDICINE (2013)
Practical challenges in integrating genomic data into the electronic health record
Abel N. Kho et al.
GENETICS IN MEDICINE (2013)
ACMG clinical laboratory standards for next-generation sequencing
Heidi L. Rehm et al.
GENETICS IN MEDICINE (2013)
Clinical Analysis and Interpretation of Cancer Genome Data
Eliezer M. Van Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias
J. E. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Implications of Clonal Genome Evolution for Cancer Medicine
Samuel Aparicio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The SMART Platform: early experience enabling substitutable applications for electronic health records
Kenneth D. Mandl et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2012)
Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics
Alfonso Valencia et al.
GENOME MEDICINE (2012)
Emerging Landscape of Genomics in the Electronic Health Record for Personalized Medicine
Mollie H. Ullman-Cullere et al.
HUMAN MUTATION (2011)
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non-Small-Cell Lung Cancer
Zengliu Su et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Exploring the Genomes of Cancer Cells: Progress and Promise
Michael R. Stratton
SCIENCE (2011)
Open Notes: Doctors and Patients Signing On
Tom Delbanco et al.
ANNALS OF INTERNAL MEDICINE (2010)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
The Meaningful Use Regulation for Electronic Health Records
David Blumenthal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Launching HITECH
David Blumenthal
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Analysis of Multiple Sarcoma Expression Datasets: Implications for Classification, Oncogenic Pathway Activation and Chemotherapy Resistance
Panagiotis A. Konstantinopoulos et al.
PLOS ONE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
Monique L. Den Boer et al.
LANCET ONCOLOGY (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Data integration and genomic medicine
Brenton Louie et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2007)
The genome-enabled electronic medical record
M. A. Hoffman
JOURNAL OF BIOMEDICAL INFORMATICS (2007)
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia
Simona Soverini et al.
CLINICAL CANCER RESEARCH (2006)
Predicting the adoption of electronic health records by physicians: When will health care be paperless?
EW Ford et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2006)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The challenge of documenting mutation across the genome: The human genome variation society approach
O Horaitis et al.
HUMAN MUTATION (2004)
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
MG Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Molecular characterisation of soft tissue tumours: a gene expression study
TO Nielsen et al.
LANCET (2002)
Share Paper
